CTOs on the Move


 
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.cardionomicinc.com
  • 2009 West Broadway Ave Ste 400, PMB 130
    Forest Lake, MN USA 55025
  • Phone: 651.964.0170

Executives

Name Title Contact Details

Funding

Cardionomic raised $20M on 10/26/2015

Similar Companies

Exogenesis Corporation

Exogenesis Corporation is a Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advogent

Advogent is a Wayne, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tokai Pharmaceuticals

Tokai Pharmaceuticals is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Scholars

Health Scholars is transforming clinical education and training. Our mission is to advance healthcare education through virtualization, making experience-based training scalable, accessible and affordable to both Healthcare and Public Safety providers.

Jenson Medical International

Jenson Medical International is a Conroe, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.